Ms. Xiaorong Zhu | Multiple Myeloma | Best Researcher Award

Ms. Xiaorong Zhu | Multiple Myeloma | Best Researcher Award

Baotou Medical College of Inner Mongolia University of Science and Technology | China

Author Profile

ORCID Id

👩‍⚕️💉Xiaorong Zhu: Aspiring Internal Medicine Physician 

🎓 Education Experience

  • 🎓2016.09-2021.07: Bachelor’s in Clinical Medicine
    Baotou Medical College, Inner Mongolia University of Science and Technology
  • 🏥2021.09-2024.07: Master’s in Internal Medicine
    Baotou Medical College, Inner Mongolia University of Science and Technology

🩺 Internship Experience

  • 🏨2019.08-2021.07: Baotou City Central Hospital (Fieldwork)
    • 🏥Completed rotations in Internal Medicine, Surgery, Obstetrics & Gynecology, and Emergency Department.
    • ⚕️Gained practical experience diagnosing and treating common diseases.
  • 🩺2021.09-2024.07: Baotou City Central Hospital (Resident Training)
    • 💉Participated in over 100 clinical cases, working closely with senior physicians.
    • 🔬Skilled in bone marrow punctures, biopsies, and other key clinical procedures.

🎯 School Experience

  • 🎓2016.09-2021.07: Undersecretary, Student Union of Central Clinical Medical School
    • 📚Organized medical seminars, attracting over 200 participants.
    • 🩺👩‍⚕️Coordinated clinical skills workshops, helping 100 students improve their skills.
    • 🤝💡Led volunteer projects, involving 300 student volunteers.

🏆 Relevant Skills

  • 📜Certified in Standardized Resident Training (Internal Medicine)
  • 📖Fluent in English (CET-4), with strong reading and writing abilities
  • ✍️Holder of Internal Medicine Qualification & Registration Certificates

🌟 Xiaorong Zhu is a dedicated physician in training, passionate about advancing patient care and mastering clinical skills in Internal Medicine. 🌿👩‍⚕️

✨Conclusion🎯

👩‍⚕️In summary, Xiaorong Zhu is a driven and skilled emerging physician with a strong foundation in Clinical Medicine and Internal Medicine. With hands-on experience in diverse medical fields, including rotations and resident training at Baotou City Central Hospital, she has developed expertise in clinical diagnosis and advanced procedures like bone marrow biopsies. Her leadership roles in academic and volunteer initiatives further demonstrate her dedication to the medical field and commitment to improving patient care. As Xiaorong continues her journey, she is poised to make significant contributions to the healthcare community. 🌟💉.

 

📊🔬NOTABLE PUBLICATION:

 

    • Function of NLRP3 inflammasome activation in multiple myeloma
      • Authors: Xiaorong Zhu, Jie Yu, Mingqiang Hua, Ning Xu, Lianjuan Wang, Lingkai Chen, Yanhong Jia, Xueyun Zhao
        Journal: Hematology
        Year: 2024

Prof. Elina Genina | Tumor Model | Best Researcher Award

Prof. Elina Genina | Tumor Model | Best Researcher Award

Saratov State University | Russia

Author Profile

Scopus

Orcid id

Google Scholar

📚 Biography: Prof. Elina A. Genina

  • 🎓 Education:

    • Saratov State University, Saratov, Russia
      • MS in Radiophysics and Electronics, 1993
      • PhD in Biophysics, 2002
      • Dr.Sc. in Biophysics, 2017
  • 🏢 Professional Experience:

    • Full Professor, Chair of Optics and Biophotonics, Saratov State University (SSU), since 2018
    • Senior Researcher, Interdisciplinary Laboratory on Biophotonics, Tomsk State University, 2014–2018
    • Associate Professor, Chair of Optics and Biophotonics, SSU, 2003–2018
    • Assistant Professor, Chair of Optics, SSU, 2002–2003
    • Engineer, Chair of Optics, SSU, 2000–2002
    • PhD Student, Chair of Optics, SSU, 1996–2001
    • Engineer, Institute of Chemistry, SSU, 1993–1997
  • 🌟 Honors and Awards:

    • George Soros PhD student awards, 1999 and 2000
    • Post-Doctoral Fellowship Award, U.S. Civilian Research and Development Foundation for the Independent States of the Former Soviet Union (CRDF), 2003
    • Welcome Trust Award, 2005
    • Nano Research Top Papers Award, 2016
  • 📚 Teaching Experience:

    • Courses on Fundamentals of Photobiology, Photomedicine, Tissue Optics, Measurement Methods in Biology and Medicine, and more
  • 📝 Research Interests:

    • Biological and medical physics, biophotonics, biomedical optics, nanobiophotonics, OCT, optical and laser measurements, photodynamic/photothermal therapy
  • 📃 Selected Papers:

    • Published numerous papers and reviews in peer-reviewed journals such as J. Biophotonics, J. Biomedical Optics, and others
  • 🎙️ Professional Activities:

    • Member of editorial boards and reviewer for various scientific journals
    • Member of international conference committees including Saratov Fall Meeting
  • 📘 Book Editor:

    • Edited “Handbook of tissue optical clearing: new prospects in optical imaging,” CRC Press, 2022
  • 🏅 Special Issues:

    • Guest editor and contributor to special issues in journals and proceedings on biophotonics technologies

📊🔬Notable Publication:

Photothermal and photodynamic therapy of tumors with plasmonic nanoparticles: challenges and prospects

Authors: Alla B Bucharskaya, Nikolai G Khlebtsov, Boris N Khlebtsov, Galina N Maslyakova, Nikita A Navolokin, Vadim D Genin, Elina A Genina, Valery V Tuchin

Journal: Materials

Year: 2022

 

Rapid ultrasound optical clearing of human light and dark skin

  • Authors: Elina A Genina, Yury I Surkov, Isabella A Serebryakova, Alexey N Bashkatov, Valery V Tuchin, Vladimir P Zharov
  • Journal: IEEE Transactions on Medical Imaging
  • Year: 2020

 

Optical clearing of tissues: issues of antimicrobial phototherapy and drug delivery

  • Authors: Valery V Tuchin, Elina A Genina, Elena S Tuchina, Anna V Svetlakova, Yulia I Svenskaya
  • Journal: Advanced Drug Delivery Reviews
  • Year: 2021

 

Optimized skin optical clearing for optical coherence tomography monitoring of encapsulated drug delivery through the hair follicles

  • Authors: Sergey M Zaytsev, Yulia I Svenskaya, Ekaterina V Lengert, Georgy S Terentyuk, Alexey N Bashkatov, Valery V Tuchin, Elina A Genina
  • Journal: Journal of Biophotonics
  • Year: 2020

 

Glycerol effects on optical, weight and geometrical properties of skin tissue

  • Authors: Vadim D Genin, Elina A Genina, Valery V Tuchin, Alexey N Bashkatov
  • Journal: Journal of Innovative Optical Health Sciences
  • Year: 2021

Prof Dr. Rommel MarioRodriguez Burbano – Oncology and Precision Medicine – Best Researcher Award

Prof Dr. Rommel MarioRodriguez Burbano - Oncology and Precision Medicine - Best Researcher Award

Ophir Loyola Hospital - Brazil

AUTHOR PROFILE

Google Scholar

Scopus

Orcid

EARLY ACADEMIC PURSUITS

Rommel Mario Rodríguez Burbano began his academic journey by earning a degree in Biomedicine from the Federal University of Pará in 1989. He then pursued further education, completing his Master's (1993) and Ph.D. (1998) in Biological Sciences (Genetics) from the Faculty of Medicine of Ribeirão Preto, University of São Paulo.

PROFESSIONAL ENDEAVORS

After completing his formal education, Rommel embarked on a diverse and impactful professional career. He conducted post-doctoral research in Morphology at the Discipline of Genetics, Escola Paulista de Medicina, Federal University of São Paulo in 2005. Currently, he holds the prestigious position of Full Professor at the Federal University of Pará.

CONTRIBUTIONS AND RESEARCH FOCUS ON ONCOLOGY AND PRECISION MEDICINE

Rommel Mario Rodríguez Burbano's contributions to academia are significant and multifaceted. His research primarily focuses on Human Genetics, Cell Biology, and Oncology. Throughout his career, he has demonstrated a keen interest in understanding molecular mechanisms underlying diseases, particularly cancer.

IMPACT AND INFLUENCE

Rommel's work has had a profound impact on the scientific community. His extensive publication record, comprising 296 scientific articles in specialized journals, one book, and seven book chapters, reflects his dedication to advancing knowledge in his field.

ACADEMIC CITATIONS

Rommel's research output has garnered considerable attention, as evidenced by his numerous academic citations. His work is widely recognized and cited by peers, contributing significantly to the advancement of scientific knowledge.

LEGACY AND FUTURE CONTRIBUTIONS

As a mentor and supervisor, Rommel has played a pivotal role in shaping the next generation of scientists. He has supervised a total of 44 master's theses, 41 doctoral theses, and mentored five postdoctoral fellows. His legacy extends beyond his own research contributions, influencing the work of numerous scholars who have benefited from his guidance and expertise.

HIGHLIGHTS

Rommel currently serves as the Coordinator of the Molecular Biology Laboratory at Hospital Ophir Loyola in Belém, Pará, indicating his leadership in translational research.He holds the Process and Molecular Biomarker patent, demonstrating his innovative approach to addressing scientific challenges.Rommel's involvement in editorial boards of 12 scientific journals and his role as a reviewer for numerous scientific publications underscore his commitment to peer-reviewed research and quality scholarship.

NOTABLE PUBLICATIONS

Homocystein, Vitamin B12 and Folic Acid as Screening Biomarkers in Early Diagnosis and Gastric Cancer Monitoring.  2024

Efficacy and Safety of Anti-CD38 Monoclonal Antibodies in Patients with Relapsed or Refractory Multiple Myeloma: A Meta-Analysis of Randomized Clinical Trials. 2024

Molecular Profile of Variants Potentially Associated with Severe Forms of COVID-19 in Amazonian Indigenous Populations. 2024 (1)

Efficacy and safety of Zolbetuximab plus chemotherapy for advanced CLDN18.2-positive gastric or gastro-oesophageal adenocarcinoma: a meta-analysis of randomized clinical trials. 2024

PARP1 Characterization as a Potential Biomarker for BCR::ABL1 p190+ Acute Lymphoblastic Leukemia. 2023

 

 

Ms. Hao Li – Tumor Immunology – Young Scientist Award

Ms. Hao Li - Tumor Immunology - Young Scientist Award

First Hospital of China Medical University - China

Author Profile

Scopus

EARLY ACADEMIC PURSUITS

Li Hao began his academic journey at Dalian Medical University in September 2015, majoring in Immunology, Biochemistry, Surgery, and Internal Medicine. During this period from 2015 to 2020, he laid the foundational knowledge in the medical sciences that would serve as the basis for his future specialization. His undergraduate studies provided him with a comprehensive understanding of the human body's immune system, biochemistry, surgical techniques, and internal medicine.Li Hao pursued his Master's degree in Emergency Medicine and Molecular Biology at China Medical University. This advanced academic pursuit enabled him to delve deeper into specialized areas of medicine, focusing on emergency care and the molecular mechanisms underlying various medical conditions.

PROFESSIONAL ENDEAVORS

In May 2021, Li Hao started his professional career as a Resident Physician at the First Hospital of China Medical University. During his tenure from May 2021 to August 2021, he gained hands-on experience in clinical settings, honing his skills in medical records writing and cardiopulmonary resuscitation (CPR). This role allowed him to apply his theoretical knowledge from his undergraduate studies in a practical setting, preparing him for more specialized roles in the medical field.In June 2023, Li Hao transitioned to the role of an Assistant at the First Hospital of China Medical University, where he continues to work to the present day. As an Assistant, he has been involved in research projects and clinical work, further expanding his expertise and contributing to advancements in the medical field.

CONTRIBUTIONS AND RESEARCH FOCUS ON TUMOR IMMUNOLOGY

Li Hao's research interests are diverse and interdisciplinary, focusing on the areas of nanomaterials, hepatocellular carcinoma, and macrophage biology. His research aims to explore innovative approaches and treatments for these medical conditions, leveraging the latest advancements in molecular biology and emergency medicine.

IMPACT AND INFLUENCE

Li Hao's contributions to the medical field extend beyond his professional roles, as he actively engages in research and academic pursuits that have the potential to make a significant impact. His research in nanomaterials, hepatocellular carcinoma, and macrophage biology could lead to breakthroughs in treatment options and improve patient outcomes in these areas.

ACADEMIC SITES

Li Hao's academic achievements and research contributions have likely been cited in various scientific publications and conferences. His interdisciplinary research in nanomaterials, hepatocellular carcinoma, and macrophage biology demonstrates his commitment to advancing medical science and contributing valuable insights to the academic community.

LEGACY AND FUTURE CONTRIBUTIONS

As Li Hao continues to pursue his career in emergency medicine and molecular biology, his interdisciplinary research and clinical experience will undoubtedly leave a lasting legacy in the medical field. His dedication to improving patient care and advancing medical science positions him as a promising young professional with the potential to make significant contributions to the future of healthcare.

NOTABLE PUBLICATIONS

Nanomaterials modulate tumor-associated macrophages for the treatment of digestive system tumors.  2024

Glutamate Chemical Exchange Saturation Transfer (GluCEST) MRI to Evaluate the Rapid Antidepressant Effects of Ketamine in the Hippocampus of Rat Depression Model. 2024 (1)

Preclinical multi-physiologic monitoring of immediate-early responses to diverse treatment strategies in breast cancer by optoacoustic imaging. 2024

Glutamate alterations in the premature infant brain during different gestational ages with glutamate chemical exchange saturation transfer imaging: a pilot study. 2023 (1)

Xenon inhalation attenuates neuronal injury and prevents epilepsy in febrile seizure Sprague-Dawley pups. 2023 (1)

 

Prof. Paolo De Simone – Oncology Therapy – Most Liked Article Award

Prof. Paolo De Simone - Oncology Therapy - Most Liked Article Award

UNIVERSITY OF PISA - Italy

Author Profile

Google Scholar
Scopus
Orcid

EARLY ACADEMIC PURSUITS

Paolo De Simone graduated summa cum laude in Medicine and Surgery from the University of Rome La Sapienza. His thesis was titled "Laparoscopic cholecystectomy in the treatment of gallstone lithiasis: prospective analysis of the results of our experience" under the supervision of Prof. Raffaello Cortesini.He earned his Specialist Diploma in General Surgery summa cum laude from the University of Rome “La Sapienza”. His thesis focused on "The role of laparoscopic surgery in the treatment of benign and malignant gastric pathologies" under the guidance of Prof. Raffaello Cortesini.Paolo De Simone achieved his PhD summa cum laude in Surgical Pathophysiology.

PROFESSIONAL ENDEAVORS

Registered in the Order of Doctors-Surgeons and Dentists of the Province of Rome with registration number 46702. He also qualified to practice the medical-surgical profession at the University of Rome “La Sapienza”. He served as a Foreign Resident-Assistant at the General Surgery Service of CHU André Vésale, Université Libre de Bruxelles, Montigny-Le-Tilleul, Belgium, and at the Thoracic and Vascular Surgery Service of the Hospital Avicenne, Bobigny, France. Paolo De Simone held several medical director positions:General Surgery Unit, Civil Hospital of Vittorio Veneto (TV),Organ Transplant Unit, San Salvatore Civil Hospital, L'Aquila,Service de Chirurgie Digestive, Hopital Erasme, Université Libre de Bruxelles, Brussels,University Liver Transplantology Unit, Pisa University Hospital.Currently, he is an Associate Professor of Surgery at the University of Pisa. He was elected Director of the School of Specialization in Surgery of the Digestive System and serves as Director of the Liver Surgery and Liver Transplant Unit, AOUP.

CONTRIBUTIONS AND RESEARCH FOCUS ON ONCOLOGY THERAPY

Appointed as the Coordinator of the regional liver transplant program by DGRT of 17 December 2018, n. 1450. He also managed clinical, scientific, and educational coordination of terminal liver failure and liver transplantation (DG AOUP Resolution 852 of 09/20/2023).His research has covered areas like laparoscopic cholecystectomy, treatment of benign and malignant gastric pathologies, and liver transplantology.

IMPACT AND INFLUENCE

As Coordinator of the Liver Transplant Program of the Tuscany Region, he has significantly contributed to the advancement of liver transplantation in the region.

LEGACY AND FUTURE CONTRIBUTIONS

Paolo De Simone's legacy lies in his extensive contributions to the fields of general surgery, liver surgery, and liver transplantology. His future contributions are anticipated in enhancing liver transplant programs, furthering research in surgical pathophysiology, and mentoring the next generation of surgeons through his academic roles.

NOTABLE PUBLICATIONS

Everolimus Mitigates the Risk of Hepatocellular Carcinoma Recurrence after Liver Transplantation.

First-in-human liver transplantation from a centenarian deceased donor after brain death.

Aging with a Liver Graft: Analysis of Very Long-Term Survivors after Liver Transplantation.

An Unexpected Case of Opisthorchis felineus Infection Revealed during Liver Transplantation.

An overview of the efficacy and safety of everolimus in adult solid organ transplant recipients.

 

Dr. Francesco Raspagliesi – Gynecologic Oncology – Best Researcher Award

Dr. Francesco Raspagliesi - Gynecologic Oncology - Best Researcher Award

Fondazione IRCCS Istituto nazionale Tumori di Milano - Italy  

Author Profile

Scopus

EARLY ACADEMIC PURSUITS

Francesco Raspagliesi began his academic journey with a Degree in Medicine and Surgery from the University of Catania, Italy, which he completed on March 7, 1981. Following this foundational education, he obtained qualifications to practice medicine in 1981 and specialized in Obstetrics and Gynecology from the University of Catania in 1985 and 1988. These early academic pursuits laid the groundwork for his future professional endeavors in the field of gynecologic oncology.

PROFESSIONAL ENDEAVORS

From 1985 to 1992, Raspagliesi served as a Research Fellow at the Fondazione IRCCS Istituto Nazionale Tumori di Milano. He continued his professional growth at the same institution, becoming a Dirigente Medico di 1° Livello from 1992 to 1999 and advancing to Dirigente Medico di 2° Livello Gynecologic Oncology Unit Director from 1999 to 2019. His long-standing association with the Fondazione IRCCS Istituto Nazionale Tumori di Milano demonstrates his commitment and dedication to the field of gynecologic oncology and patient care.

CONTRIBUTIONS AND RESEARCH FOCUS ON GYNECOLOGIC ONCOLOGY

Throughout his career, Raspagliesi has made significant contributions to the field of Obstetrics and Gynecology. His research and clinical work have focused on gynecologic oncology, particularly in the treatment and management of gynecologic cancers. His expertise and leadership as the Gynecologic Oncology Unit Director have contributed to advancements in the diagnosis, treatment, and care of patients with gynecologic cancers.

IMPACT AND INFLUENCE

As a respected figure in the field of gynecologic oncology, Raspagliesi's work has had a profound impact on patient care, research, and education. His leadership roles and contributions to research have helped shape the way gynecologic cancers are treated and managed, influencing clinical practice and improving patient outcomes.

LEGACY AND FUTURE CONTRIBUTIONS

Francesco Raspagliesi's legacy in the field of Obstetrics and Gynecology is characterized by his dedication to patient care, leadership in gynecologic oncology, and contributions to research and education. His continued commitment to advancing the field through research, mentorship, and clinical practice ensures that his influence will be felt by future generations of gynecologic oncologists.

NOTABLE PUBLICATIONS

Real world data of niraparib in platinum sensitive relapsed ovarian cancer: A multicenter experience of the MITO group.  2024

Sentinel node mapping in high-intermediate and high-risk endometrial cancer: Analysis of 5-year oncologic outcomes. 2024

Reproductive outcomes after conservative treatment in early and advanced stage MOGCTs.  2024

Impact of Cold Ischemia on the Stability of 1H-MRS-Detected Metabolic Profiles of Ovarian Cancer Specimens. 2024

Concurrent Endometrial Cancer in Women with Atypical Endometrial Hyperplasia: What Is the Predictive Value of Patient Characteristics? (2) 2024

 

 

Cancer Treatment, Therapies and Nursing

Cancer Treatment, Therapies and Nursing

Introduction: Cancer Treatment, Therapies, and Nursing represent the multifaceted approach to addressing cancer, combining cutting-edge medical interventions, supportive care, and compassionate nursing to improve patient outcomes and enhance their quality of life. These components are integral in the comprehensive battle against cancer.

Subtopics in Cancer Treatment, Therapies, and Nursing:

Oncology Nursing and Patient Care: Explore the pivotal role of oncology nurses in providing personalized care, managing symptoms, and offering emotional support to cancer patients throughout their treatment journey.

Surgery in Cancer Treatment: Delve into the various surgical procedures used to remove tumors, biopsy tissues, and reconstruct affected areas, and their significance in the overall cancer treatment plan.

Radiation Therapy: Understand the principles and advancements in radiation therapy, including techniques like IMRT and proton therapy, and how they target cancer cells while minimizing damage to healthy tissue.

Chemotherapy and Targeted Therapies: Examine the different types of chemotherapy and targeted therapies, their mechanisms of action, and the evolving landscape of drug development in cancer treatment.

Palliative and Supportive Care: Explore the importance of palliative care in managing cancer-related symptoms, improving the patient’s quality of life, and addressing end-of-life considerations, alongside the crucial role of supportive care services.

Integrative and Complementary Therapies
: Investigate complementary approaches such as acupuncture, yoga, and mindfulness, which can complement traditional cancer treatments and aid in symptom management and emotional well-being.

Precision Medicine in Oncology: Understand how precision medicine tailors cancer treatment to an individual’s genetic and molecular profile, optimizing therapy selection and minimizing side effects.

Survivorship Programs: Learn about survivorship programs that focus on the long-term health and well-being of cancer survivors, addressing physical, psychological, and social aspects of post-treatment life.

Emerging Therapies and Clinical Trials: Explore promising experimental therapies and the importance of clinical trials in advancing cancer treatment options, as well as the roles

 

Medical Oncology

Medical Oncology

Introduction to Medical Oncology: Medical Oncology is a specialized branch of medicine dedicated to the diagnosis, treatment, and management of cancer. This field plays a pivotal role in improving the lives of cancer patients through various treatment modalities and cutting-edge research. Within the realm of Medical Oncology, several key subtopics are essential for understanding and addressing the complexities of cancer care:

Chemotherapy and Targeted Therapies: Chemotherapy involves the use of drugs to kill or slow the growth of cancer cells, while targeted therapies focus on specific molecular abnormalities within cancer cells. Understanding these treatment options is crucial for medical oncologists to tailor therapies for individual patients.

Immunotherapy: Immunotherapy harnesses the body’s immune system to combat cancer. This groundbreaking approach has revolutionized cancer treatment by enhancing the body’s natural defenses against cancer cells.

Precision Medicine: Precision medicine in oncology involves customizing treatment plans based on a patient’s unique genetic and molecular profile. It allows for more personalized and effective cancer treatments, minimizing side effects.

Palliative Care: Palliative care in Medical Oncology is vital for improving the quality of life for cancer patients. It focuses on symptom management, pain relief, and emotional support to enhance patients’ overall well-being.

Clinical Trials and Research: Ongoing research and clinical trials are at the forefront of Medical Oncology. Investigating new treatments, therapies, and breakthroughs in cancer care is essential for improving patient outcomes and advancing the field.

These subtopics illustrate the multidimensional nature of Medical Oncology, where a comprehensive approach is taken to address the complexities of cancer treatment and patient care.